Navigation Links
Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
Date:4/22/2008

olides modulate cell signaling pathways involved in the host cell's innate defense against viruses. Thiazolides can be administered orally and are not associated with side effects commonly associated with use of interferon. Nitazoxanide was discovered by Jean-Francois Rossignol, M.D., Ph.D., Chairman and Chief Science Officer of Romark, and was initially developed by Romark and approved for marketing in the United States as a treatment of cryptosporidiosis.

About Hepatitis C

Hepatitis C is a blood-borne infectious disease that is caused by the hepatitis C virus (HCV). It is the most common cause of chronic hepatitis in the U.S. and may eventually lead to cirrhosis, liver cancer and liver failure. The disease is transmitted by contact with HCV-infected blood. A large majority of those infected do not show symptoms, but fatigue, abdominal pain and nausea can be common. The current standard treatment of care, peginterferon and ribavirin, is effective in about half of all patients treated. According to the Centers for Disease Control, HCV affects an estimated 4.1 million Americans.

About Romark Laboratories

Romark Laboratories (http://www.romark.com), a privately held biopharmaceutical company, has discovered and developed a new class of small molecule antivirals known as thiazolides. The Company is developing nitazoxanide, the first of the thiazolide class, for the treatment of chronic hepatitis C, and is developing other new thiazolides for treating viral diseases including chronic hepatitis B. Alinia(R) (nitazoxanide) is approved by the U.S. Food and Drug Administration and marketed by Romark for the treatment of Cryptosporidium and Giardia infection.

REFERENCES:

(1) Interim Data from a Randomized Controlled Trial of Nitazoxanide-

Peginterferon-Ribavirin, Nitazoxanide-Peginterferon and Peginterferon-

Ribavirin in the treatment of Patients with Chroni
'/>"/>

SOURCE Romark Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. Romark Laboratories Raises $18 Million in Institutional Financing
3. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... , Oct. 30, 2014 Today Eli Lilly ... of its long-standing technology transfer program to increase the ... in 2003, the effort included Lilly donating manufacturing technology ... China , India ... South Africa – all MDR-TB ,hot spots., ...
(Date:10/27/2014)... 27, 2014 Research and Markets has ... 2014-2018" report to their offering. H1N1 ... a variant of the swine H1N1 virus, known as H1N1v ... nose, throat, and lungs. H1N1 virus is an RNA virus ... animal species such as humans, swine, birds, seals, and horses. ...
(Date:10/27/2014)... EAST TAUNTON, Mass. , Oct. 27, 2014 /PRNewswire/ ... the $15 billion global hip and knee replacement device market, ... and knee replacement technology at the American Association of ... the Sheraton Dallas Hotel in Dallas, Texas ... is a Bronze corporate partner of the organization. ...
Breaking Medicine Technology:Lilly Shares Insights from Decade-Long Technology Transfer Experience 2Lilly Shares Insights from Decade-Long Technology Transfer Experience 3Lilly Shares Insights from Decade-Long Technology Transfer Experience 4Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 2Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 3OMNIlife science to Exhibit at American Association of Hip and Knee Surgeons 24th Annual Meeting in Dallas November 6-9 2OMNIlife science to Exhibit at American Association of Hip and Knee Surgeons 24th Annual Meeting in Dallas November 6-9 3
... Bulletin Board: GOVX ) announced today the publication ... its HIV/AIDS vaccine products. The article, titled "Phase 1 Safety ... Vaccines Expressing HIV-1 Virus-like Particles," will appear in the March ... Diseases . A PDF of the article is available at ...
... Inc., a leader in room temperature biostability technology, ... (IQT). IQT is the independent, strategic investment firm ... mission of the U.S. Intelligence Community. ... pioneered recent innovations in ambient storage of biological ...
Cached Medicine Technology:GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases 2GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases 3GeoVax Announces Publication of Phase 1 Clinical Trial in The Journal of Infectious Diseases 4Biomatrica Secures Strategic Investment from IQT 2Biomatrica Secures Strategic Investment from IQT 3
(Date:10/30/2014)... Steven Reinberg HealthDay Reporter , ... to men with prostate cancer who also have certain heart ... cause, a new study suggests. , , The therapy in question ... cancer to reduce levels of male hormones to prevent the ... the current research, this hormone therapy was linked to triple ...
(Date:10/30/2014)... Home Care Assistance – Halton/Peel Region ( http://www.GreaterTorontoHomeCare.ca ... care, is weighing in on a recent study linking ... performed by the University of Illinois, analyzed 88 patients ... week-long period and observed how much time was spent ... the structural soundness of the white matter in each ...
(Date:10/30/2014)... San Francisco, California (PRWEB) October 30, 2014 ... 5.75 billion by 2020, according to a new study ... consumption, coupled with surging demand for sugar and fat ... expected to augment the demand for prebiotics over the ... http://www.grandviewresearch.com/industry-analysis/prebiotics-market , Food & beverage was ...
(Date:10/30/2014)... Rock Hill, South Carolina (PRWEB) October 30, 2014 ... a muscle, and should be more vigorously exercised to ... Grewal. He recently authored the book ‘Dementia Express: Lose ... , The book uses counterintuitive reasoning and sometimes conflicting ... an obstacle course for the mind, a reader must ...
(Date:10/30/2014)... Seattle, WA (PRWEB) October 30, 2014 Sound ... their decision infographic that will assist people any time they ... people discover the right answer by leading them through a ... a resolution to their initial query. , There are many ... or not to use an answering service . This ...
Breaking Medicine News(10 mins):Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 2Health News:Hormone Therapy May Up Heart-Related Deaths in Some Prostate Cancer Patients 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Responds to Study Linking Exercise to Healthier Senior Brains 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 2Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 3Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 4Health News:Prebiotics Market Is Expected To Grow At A CAGR Of 9.3% From 2014 To 2020: Grand View Research, Inc. 5Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2Health News:Sound Telecom Produces Decision Infographic to Aid Businesses 2
... Reporter , WEDNESDAY, Dec. 21 (HealthDay News) -- Problems in ... be at the heart of this learning disorder, new research ... issue of the journal Neuron , may one day ... diagnosed with this common yet still ultimately mysterious condition. ...
... HealthDay Reporter , WEDNESDAY, Dec. 21 (HealthDay ... protein shakes and soup followed by adding low-calorie, high-protein ... which may lessen joint pain and improve their quality ... might also help people whose obesity makes it impossible ...
... Dec. 21 (HealthDay News) -- Ludwig van Beethoven was arguably one ... he was deaf by the end of his career. Now, ... suggests that the progression of his deafness may have shaped his ... Netherlands analyzed three styles of Beethoven,s compositions. In a letter to ...
... induce a rapid weight decline, mainly in the first ... regain, despite continued dieting. The partial regain may ... now shows that improvements to health remain even if ... online in Diabetes Care (Print: February 2012) ...
... 50 per cent more likely to be admitted to hospital ... a study has found. Scots of Indian and Pakistani ... both conditions than people of white Scottish ethnicity. Those ... to hospital with chest pain compared with white Scots, according ...
... beef can contribute to a heart-healthy diet in the same ... DASH diet -- Dietary Approaches to Stop Hypertension -- is ... and reduce risk of heart disease. People following the DASH ... much beef. According to the Centers for Disease Control about ...
Cached Medicine News:Health News:Scientists Probe the Origins of Dyslexia 2Health News:Diet Might Help Those Immobilized by Knee Osteoarthritis 2Health News:Diet Might Help Those Immobilized by Knee Osteoarthritis 3Health News:Did Beethoven's Hearing Loss Shape His Compositions? 2Health News:More reasons to keep this New Year's weight loss resolution uncovered by Ben-Gurion U researchers 2Health News:More reasons to keep this New Year's weight loss resolution uncovered by Ben-Gurion U researchers 3Health News:Heart disease study highlights Scottish ethnic groups most at risk 2Health News:Having a cow can be a heart healthy choice 2
... is a monomeric protein produced and stored ... GH is released from the pituitary into ... the regulatory control of hypothalamic somatostatin (SS) ... and frequency of GH release appears to ...
... or somatomedin C) is a 7.6 kDa peptide ... a potent mitogen of cellular proliferation, exerting its ... the circulation, IGF-I is bound to IGF-binding proteins ... IGF-I by modulating the interaction of IGF-I with ...
... Insulin-like growth factor I (IGF-I or somatomedin ... in the liver. It acts as a potent ... binding to specific cell-surface receptors. In the circulation, ... appear to regulate the actions of IGF-I by ...
... a potent naturally occurring androgen produced ... cholestenone 5a-reductase [1]. The concentrations ... peripheral tissues, including genital skin and ... in apparent association with the nuclear ...
Medicine Products: